Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Minimal Optimal Dose of Sugammadex in Elective Surgery

Trial Profile

Minimal Optimal Dose of Sugammadex in Elective Surgery

Phase of Trial: Phase IV

Latest Information Update: 21 Feb 2019

At a glance

  • Drugs Sugammadex (Primary)
  • Indications Neuromuscular blockade
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Feb 2019 Status changed from recruiting to completed.
    • 30 Jul 2018 Planned primary completion date changed from 30 Jun 2018 to 30 Sep 2018.
    • 07 May 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top